Selective agonists and antagonists to thyroid hormone action

Thyroid

Volumn 15, Issue 4, 2005, Pages 336-337

  Kraiem, Zaki ^a,b  

^a CARMEL MEDICAL CENTER   (Israel)

^b TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

3,5 DIIODOTHYROPROPIONIC ACID; AMIODARONE; ANTITHYROID AGENT; DEBUTYLDRONEDARONE; DEETHYLAMIODARONE; DRONEDARONE; DRUG METABOLITE; HORMONE RECEPTOR BLOCKING AGENT; HORMONE RECEPTOR STIMULATING AGENT; KB 141; PROPYLTHIOURACIL; RALOXIFENE; TAMOXIFEN; THIAMAZOLE; THYROID HORMONE RECEPTOR; THYROID HORMONE RECEPTOR ALPHA; THYROID HORMONE RECEPTOR ALPHA1; THYROID HORMONE RECEPTOR BETA; THYROID HORMONE RECEPTOR BETA1; THYROMIMETIC AGENT; TRIACYLGLYCEROL; UNCLASSIFIED DRUG;

CHOLESTEROL BLOOD LEVEL; CLINICAL TRIAL; CONFERENCE PAPER; DRUG DESIGN; DRUG INHIBITION; DRUG RECEPTOR BINDING; DRUG SCREENING; GENE EXPRESSION; HEART ARRHYTHMIA; HEART FAILURE; HUMAN; HYPERTHYROIDISM; HYPOTHYROIDISM; NONHUMAN; PRIORITY JOURNAL; TACHYCARDIA; THYROID CRISIS; THYROID HORMONE SYNTHESIS; THYROIDECTOMY; TRIACYLGLYCEROL BLOOD LEVEL; WEIGHT REDUCTION;

ANIMALS; ANTITHYROID AGENTS; HUMANS; RECEPTORS, THYROID HORMONE; THYROID HORMONES; THYROTROPIN;

EID: 18744400524     PISSN: 10507256     EISSN: None     Source Type: Journal    
DOI: 10.1089/thy.2005.15.336     Document Type: Conference Paper

References (11)

1. Riggs BL, Hartmann LC 2003 Selective estrogen receptor modulators - mechanisms of action and application to clinical practice. N Engl J Med 348:618-629.
2. Baxter JD, Dillmann WH, West BL, Huber R, Furlow JD, Fletterick RJ, Webb P, Apriletti JW, Scanlan TS 2001 Selective modulation of thyroid hormone receptor action. J Steroid Biochem Mol Biol 76:31-42.
3. Freitas FRS, Moriscot AS, Jorgetti V, Soares AG, Passarelli M, Scanlan TS, Brent GA, Bianco AC, Gouveia CHA 2003 Spared bone mass in rats treated with thyroid hormone receptor TRβ-selective compound GC-1. Am J Physiol Endocrinol Metab 285:E1135-E1141.
4. Grover GJ, Egan DM, Sleph PG, Beehler BC, Chiellini G, Nguyen N-H, Baxter JD, Scanlan TS 2004 Effects of the thyroid hormone receptor agonist GC-1 on metabolic rate and cholesterol in rats and primates: Selective actions relative to 3,5,3′-triiodo-L-thyronine. Endocrinology 145:1656 -1661.
5. Grover GJ, Mellstrom K, Ye L, Malm J, Bladh LG, Sleph PJ, Smith MA, George R, Vennstrom B, Mookhtiar K, Horvath R, Speelman J, Egan D, Baxter JD 2003 Selective thyroid hormone receptor-β activation: A strategy for reduction of weight, cholesterol, and lipoprotein (a) with reduced cardiovascular liability. PNAS 100:10067-10072.
6. Morkin E, Pennock GD, Spooner PH, Bahl JJ, Goldman S 2002 Clinical and experimental studies on the use of 3,5-diiodothyropropionic acid, a thyroid hormone analogue, in heart failure. Thyroid 12:527-533.
7. Forini F, Nicolini G, Balzan S, Ratto GM, Murzi B, Vanini V, Iervasi G 2004 Amiodarone inhibits the 3,5,3′-triiodothronine-dependent increase of sodium/potassium adenosine triphosphatase activity and concentration in human atrial myocardial tissue. Thyroid 14:493-499.
8. Webb P, Nguyen NH, Chiellini G, Yoshihara HIA, Lima STC, Apriletti JW, Ribeiro RCJ, Marimuthu A, West BL, Goede P, Mellstrom K, Nilsson S Kushner PJ, Fletterick RJ, Scanlan TS, Baxter JD 2003 Design of thyroid hormone receptor antagonists from first principles. J Steroid Biochem Mol Biol 83:59-73.
9. van Beeren HC, Jong WMC, Kaptein E, Visser TJ, Bakker O, Wiersinga WM 2003 Dronedarone acts as selective inhibitor of 3,5,3′-triiodothyronine binding to thyroid hormone receptor-α1: In vitro and in vivo evidence. Endocrinology 144:552-558.
10. Lim W, Nguyen NH, Yang HY, Scanlan TS, Furlow JD 2002 A thyroid hormone antagonist that inhibits thyroid hormone action in vivo. J Biol Chem 277:35664-35670.
11. Fares FA, Levi F, Reznick AZ, Kraiem Z 2001 Engineering a potential antagonist of human thyrotropin and thyroid-stimulating antibody. J Biol Chem 276:4543-4548.